Kreos Capital

Kreos Capital is a prominent provider of growth debt financing, specializing in supporting high-growth companies across Europe and Israel. Since its inception in 1998, the firm has committed over €5.7 billion across more than 750 transactions, assisting over 570 companies in the technology and healthcare sectors. Their investment focus spans various sub-sectors, including fintech, enterprise software, cybersecurity, semiconductors, digital marketing, AI, drug and treatment development, medical products and devices, and healthcare technology.

The firm's investment strategy is characterized by a flexible and tailored approach, offering debt facilities that match the evolving needs of high-growth companies. With significant financial backing from blue-chip institutional investors and a robust infrastructure, Kreos Capital provides support at every stage of a company's growth lifecycle—from early-stage development to late-stage growth, including pre and post-IPO phases. Their international team, with extensive entrepreneurial, debt financing, and equity investing experience, covers local European markets from locations in London, Tel Aviv, and Stockholm.

Kreos Capital's commitment to sustainability and Environmental, Social, and Governance (ESG) considerations is integral to their business operations. By integrating these factors into each step of their investment process and daily management, they aim to create lasting benefits for stakeholders, ecosystems, and communities. This dedication reflects their broader mission to support high-growth companies with additional capital and flexibility throughout their business cycles, fostering long-term partnerships with both management teams and equity sponsors.